A detailed history of North Point Portfolio Managers Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, North Point Portfolio Managers Corp holds 5,126 shares of LLY stock, worth $4.01 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
5,126
Previous 906 465.78%
Holding current value
$4.01 Million
Previous $820,000 453.78%
% of portfolio
0.77%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $3.26 Million - $4.05 Million
4,220 Added 465.78%
5,126 $4.54 Million
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $130,476 - $163,627
180 Added 24.79%
906 $820,000
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $27,833 - $37,237
47 Added 6.92%
726 $564,000
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $80,879 - $95,346
154 Added 29.33%
679 $395,000
Q3 2023

Oct 26, 2023

BUY
$434.7 - $599.3 $26,951 - $37,156
62 Added 13.39%
525 $281,000
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $408,962 - $546,830
-1,166 Reduced 71.58%
463 $217,000
Q3 2022

Oct 25, 2022

SELL
$296.48 - $337.87 $3,557 - $4,054
-12 Reduced 0.73%
1,629 $527,000
Q3 2021

Oct 20, 2021

SELL
$221.6 - $272.71 $3,324 - $4,090
-15 Reduced 0.91%
1,641 $379,000
Q4 2020

Jan 28, 2021

SELL
$130.46 - $172.63 $1,304 - $1,726
-10 Reduced 0.6%
1,656 $280,000
Q4 2019

Feb 20, 2020

BUY
$106.92 - $132.43 $178,128 - $220,628
1,666 New
1,666 $219,000
Q2 2019

Aug 02, 2019

SELL
$110.79 - $129.32 $184,576 - $215,447
-1,666 Closed
0 $0
Q1 2019

Apr 24, 2019

SELL
$111.31 - $131.02 $184,663 - $217,362
-1,659 Reduced 49.89%
1,666 $216,000
Q4 2018

Jan 24, 2019

SELL
$105.9 - $118.64 $95,310 - $106,776
-900 Reduced 21.3%
3,325 $385,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $325,620 - $361,406
4,225
4,225 $361,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track North Point Portfolio Managers Corp Portfolio

Follow North Point Portfolio Managers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Point Portfolio Managers Corp, based on Form 13F filings with the SEC.

News

Stay updated on North Point Portfolio Managers Corp with notifications on news.